LEGN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Not a good buy right now for an impatient trader: the setup is still a strong downtrend (SMA_200 > SMA_20 > SMA_5) with weak momentum, so oversold can stay oversold.", "Price is sitting right on/just below a key support zone (S1 \u2248 16.60; pre-market \u2248 16.50). A clean reclaim of ~16.60\u201318.15 would improve the odds of a tradable bounce; without that, downside risk remains elevated.", "Intellectia Proprietary Trading Signals", "- AI Stock Picker: no signal on given stock today.", "- SwingMax: No signal on given stock recently.", "No recent news catalysts and no notable hedge fund/insider trend shifts provided to justify urgent dip-buying today.", "Politicians/Congress: No recent congress trading data available (no signal from that channel)."]
["Trend: Bearish (SMA_200 > SMA_20 > SMA_5), indicating the broader trend is still down.", "Momentum: MACD histogram -0.281 (below zero). Negative but contracting, which can precede a short-lived bounce, but it is not a confirmed reversal.", "RSI: RSI_6 = 13.56 (extremely oversold). This increases bounce probability, but it\u2019s a lower-quality entry when the moving-average stack is still bearish.", "Key levels: Pivot 18.154 (major reclaim level). Support S1 16.599 (being tested pre-market), then S2 15.638. Resistance R1 19.708, R2 20.669.", "Pattern-based forward odds: ~40% chance of -1.29% next day, -4.26% next week, +2.76% next month (near-term skew still negative)."]
plus contracting negative MACD can set up a reflex bounce if support (~16.
holds.", "Options flow is strongly call-skewed (P/C volume 0.11), implying traders are leaning bullish at current depressed prices.", "Analyst upside (several Overweight/Buy ratings with targets far above current price) suggests long-term perceived undervaluation if Carvykti growth remains intact."]
citing sluggish demand/toxicity concerns and competition\u2014this is an overhang on near-term sentiment.", "No news this week = no clear event-driven catalyst to force a reversal today."]
["Latest provided quarter: 2025/Q3.", "Revenue: $272.33M, +69.99% YoY (strong top-line growth).", "Profitability: Net income -$39.69M (reported as down -68.33% YoY) and EPS -0.11 (down -67.65% YoY), indicating earnings pressure despite revenue growth.", "Margins: Gross margin 57.66%, down 11.81% YoY, a negative trend that can weigh on valuation until it stabilizes."]
["Recent trend: Multiple price target cuts across the Street (Barclays 90\u219280, H.C. Wainwright 60\u219250, UBS 54\u219248, Morgan Stanley 83\u219250, Cantor 75\u219274), indicating tempered near-term expectations despite continued long-term optimism from several firms.", "Notable negative change: TD Cowen downgraded to Hold (Buy\u2192Hold) and cut PT to $21 from $62, citing slower uptake, toxicity concerns, and competition.", "Notable positive view: Oppenheimer initiated Outperform with $75 PT, arguing concerns are overdone and risk/reward is skewed to upside.", "Wall Street pros: Carvykti leadership/sales scale, path to profitability narrative, and perceived undervaluation at depressed price levels.", "Wall Street cons: demand elasticity/uptake pace, safety/toxicity perception, and competitive threats (Anito-cel/Dara-Tec and broader BCMA CAR-T noise)."]
